Oral Dextromethorphan for the Treatment of Diabetic Macular Edema: Results From a Phase I/II Clinical Study

PURPOSE: The activation of microglia, the primary innate immune cell resident in the retina, produces inflammatory mediators, which underlie changes in diabetic retinopathy including increased vascular permeability. This study evaluates the safety and efficacy of dextromethorphan, a drug capable of...

Descripción completa

Detalles Bibliográficos
Autores principales: Valent, David J., Wong, Wai T., Chew, Emily Y., Cukras, Catherine A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Association for Research in Vision and Ophthalmology 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6300336/
https://www.ncbi.nlm.nih.gov/pubmed/30584490
http://dx.doi.org/10.1167/tvst.7.6.24

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6300336/
https://www.ncbi.nlm.nih.gov/pubmed/30584490
http://dx.doi.org/10.1167/tvst.7.6.24

Ejemplares similares